AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2024
Aug 6, 2024
30826_dirs_2024-08-05_0cb11877-3b58-45a7-b0b9-73db5c9b77ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-08-02
Reporting Person: KURIYEL RALF (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-02 | Common Stock | S | 6973 | $159.36 | Disposed | 12288 | Direct |
| 2024-08-02 | Common Stock | M | 175 | $86.10 | Acquired | 12463 | Direct |
| 2024-08-02 | Common Stock | S | 175 | $158.85 | Disposed | 12288 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-02 | Stock Option (Right to Buy) | $86.10 | M | 175 | Acquired | 2030-02-27 | Common Stock (175) | Direct |
Footnotes
F1: This option is fully vested and exercisable.
Exhibit 24.1: Power of Attorney
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23